日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Epidural Patching Outcomes and Predictors of Benefit in Patients With Suspected CSF Leak Nonconforming to ICHD-3 Criteria

疑似脑脊液漏但不符合ICHD-3标准患者的硬膜外补片治疗长期疗效及获益预测因素

Carroll, Ian; Han, Lichy; Zhang, Niushen; Cowan, Robert P; Lanzman, Bryan; Hashmi, Syed; Barad, Meredith J; Peretz, Addie; Moskatel, Leon; Ogunlaja, Oyindamola; Hah, Jennifer M; Hindiyeh, Nada; Barch, Carol; Bozkurt, Selene; Hernandez-Boussard, Tina; Callen, Andrew L

Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy

增生性镰状视网膜病变患者眼中血管生成介质血管生成素样 4 的表达

Kathleen Jee, Murilo Rodrigues, Fabiana Kashiwabuchi, Brooks P Applewhite, Ian Han, Gerard Lutty, Morton F Goldberg, Gregg L Semenza, Silvia Montaner, Akrit Sodhi

Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial

糖尿病性黄斑水肿中的促通透性因子;用 Ozurdex 治疗糖尿病性黄斑水肿的试验

Peter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, Adrienne W Scott, Ingrid Zimmer-Galler, Syed M Shah, Adam S Wenick, Christopher J Brady, Ian Han, Lingmin He, Roomasa Channa, David Poon, Catherine Meyerle, Mary Beth Aronow, Akrit Sodhi, James T Handa, Saleema Kherani, Yong Han, Raafay Sophie, Guohu

Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study

地塞米松植入治疗视网膜静脉阻塞后的促通透性因素;Ozurdex 治疗视网膜静脉阻塞 (ORVO) 研究

Peter A Campochiaro, Gulnar Hafiz, Tahreem A Mir, Adrienne W Scott, Raafay Sophie, Syed M Shah, Howard S Ying, Lili Lu, Connie Chen, J Peter Campbell, Saleema Kherani, Ingrid Zimmer-Galler, Adam Wenick, Ian Han, Yannis Paulus, Akrit Sodhi, Guohua Wang, Jiang Qian

A nicotinic acetylcholine receptor mutation conferring target-site resistance to imidacloprid in Nilaparvata lugens (brown planthopper)

尼古丁乙酰胆碱受体突变赋予褐飞虱对吡虫啉的靶位抗性

Liu, Zewen; Williamson, Martin S; Lansdell, Stuart J; Denholm, Ian; Han, Zhaojun; Millar, Neil S